These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 19648961)

  • 1. Compartmentalized cancer drug discovery targeting mitochondrial Hsp90 chaperones.
    Kang BH; Altieri DC
    Oncogene; 2009 Oct; 28(42):3681-8. PubMed ID: 19648961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAP1: a viable therapeutic target for future cancer treatments?
    Lettini G; Maddalena F; Sisinni L; Condelli V; Matassa DS; Costi MP; Simoni D; Esposito F; Landriscina M
    Expert Opin Ther Targets; 2017 Aug; 21(8):805-815. PubMed ID: 28664757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90.
    Kang BH; Plescia J; Song HY; Meli M; Colombo G; Beebe K; Scroggins B; Neckers L; Altieri DC
    J Clin Invest; 2009 Mar; 119(3):454-64. PubMed ID: 19229106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRAP1 regulation of mitochondrial life or death decision in cancer cells and mitochondria-targeted TRAP1 inhibitors.
    Kang BH
    BMB Rep; 2012 Jan; 45(1):1-6. PubMed ID: 22281005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat-shock protein 90 (Hsp90) as anticancer target for drug discovery: an ample computational perspective.
    Kumalo HM; Bhakat S; Soliman ME
    Chem Biol Drug Des; 2015 Nov; 86(5):1131-60. PubMed ID: 25958815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat shock protein 90 inhibitors as therapeutic agents.
    Gomez-Monterrey I; Sala M; Musella S; Campiglia P
    Recent Pat Anticancer Drug Discov; 2012 Sep; 7(3):313-36. PubMed ID: 22338602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the mitochondrial Hsp90 chaperone network: a novel, efficient treatment strategy for cancer?
    Siegelin MD
    Cancer Lett; 2013 Jun; 333(2):133-46. PubMed ID: 23376257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSP90 and Co-chaperones: Impact on Tumor Progression and Prospects for Molecular-Targeted Cancer Therapy.
    Jafari A; Rezaei-Tavirani M; Farhadihosseinabadi B; Taranejoo S; Zali H
    Cancer Invest; 2020 May; 38(5):310-328. PubMed ID: 32274949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRAP-1, the mitochondrial Hsp90.
    Altieri DC; Stein GS; Lian JB; Languino LR
    Biochim Biophys Acta; 2012 Mar; 1823(3):767-73. PubMed ID: 21878357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paralog Specificity Determines Subcellular Distribution, Action Mechanism, and Anticancer Activity of TRAP1 Inhibitors.
    Park HK; Jeong H; Ko E; Lee G; Lee JE; Lee SK; Lee AJ; Im JY; Hu S; Kim SH; Lee JH; Lee C; Kang S; Kang BH
    J Med Chem; 2017 Sep; 60(17):7569-7578. PubMed ID: 28816449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-terminal modulators of heat shock protein of 90 kDa (HSP90): State of development and modes of action.
    Bickel D; Gohlke H
    Bioorg Med Chem; 2019 Nov; 27(21):115080. PubMed ID: 31519378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat Shock Protein 90 Inhibition in Cancer Drug Discovery: From Chemistry to Futural Clinical Applications.
    Özgür A; Tutar Y
    Anticancer Agents Med Chem; 2016; 16(3):280-90. PubMed ID: 26295332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of Mitochondrial Metabolic Reprogramming and Oxidative Stress to Overcome Chemoresistance in Cancer.
    Avolio R; Matassa DS; Criscuolo D; Landriscina M; Esposito F
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31947673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting protein-protein interactions of Hsp90 as a novel approach for targeting cancer.
    Dutta Gupta S; Bommaka MK; Banerjee A
    Eur J Med Chem; 2019 Sep; 178():48-63. PubMed ID: 31176095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chaperone substrate provides missing link for cancer drug discovery.
    Byrd KM; Blagg BSJ
    J Biol Chem; 2018 Feb; 293(7):2381-2382. PubMed ID: 29453286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsp90 inhibition by PU-H71 induces apoptosis through endoplasmic reticulum stress and mitochondrial pathway in cancer cells and overcomes the resistance conferred by Bcl-2.
    Gallerne C; Prola A; Lemaire C
    Biochim Biophys Acta; 2013 Jun; 1833(6):1356-66. PubMed ID: 23485394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HSP90 inhibition: two-pronged exploitation of cancer dependencies.
    Travers J; Sharp S; Workman P
    Drug Discov Today; 2012 Mar; 17(5-6):242-52. PubMed ID: 22245656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial compartmentalized protein folding and tumor cell survival.
    Altieri DC
    Oncotarget; 2011 Apr; 2(4):347-51. PubMed ID: 21555789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Posttranslational Modifications on the Anticancer Activity of Hsp90 Inhibitors.
    Woodford MR; Dunn D; Miller JB; Jamal S; Neckers L; Mollapour M
    Adv Cancer Res; 2016; 129():31-50. PubMed ID: 26916000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial HSP90s and tumor cell metabolism.
    Altieri DC
    Autophagy; 2013 Feb; 9(2):244-5. PubMed ID: 23108292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.